Xarelto Lawsuit Information for Blood Thinner Patients
Popular prescription anticoagulant Xarelto® belongs to a newer drug class that doesn’t require monthly blood monitoring, unlike warfarin. The U.S. Food and Drug Administration initially approved Xarelto (rivaroxaban) in July 2011. Within three years, injured patients sued the drug’s manufacturers for failing to properly warn consumers about potentially life-threatening complications. If you developed blood clots or uncontrolled internal bleeding while taking Xarelto, you may qualify for financial compensation. Families may also file a wrongful death lawsuit on any Xarelto victim’s behalf to seek justice against the drug’s manufacturer. Review current Xarelto lawsuit information before filing your own anticoagulant injury claim.
Xarelto Lawsuit Information: What Is Xarelto?
Bayer and Janssen Pharmaceuticals, a Johnson & Johnson subsidiary company, both manufacture rivaroxaban (Xarelto). Xarelto is extremely popular with U.S. consumers due to its ability to treat a variety of medical issues, including:
- reducing risk of blood clots as well as strokes in people with atrial fibrillation
- treating deep vein thrombosis (DVT) as well as pulmonary embolism (PE)
- lowering blood clot risks for hip or knee replacement surgery patients
Xarelto suffered an early backlash from the FDA in June 2013 due to “misleading claims” about the drug’s efficacy and associated risks. In fact, the FDA’s letter warns J&J about minimizing Xarelto’s risks in a 2013 ad found in WebMD magazine. One year later, Ruth E. McGowan filed the first wrongful death Xarelto lawsuit on behalf of her father, Thomas C. Dunkley. Since 2014, Xarelto claims across the U.S. were centralized into a class-action lawsuit overseen by Louisiana Judge Eldon E. Fallon. Serious Xarelto side effects include uncontrolled internal bleeding, pulmonary embolism, deep vein thrombosis — and in some cases, even death. At 17.5% of the U.S. prescription blood thinner market in 2015, Xarelto’s the most popular new wave anticoagulant medication. Unfortunately, there’s currently no known Xarelto reversal agent available. As a result, uncontrolled bleeding episodes can be fatal for Xarelto patients.
Xarelto Lawsuit Information: Allegations Similar to Eliquis, Pradaxa Claims
Janssen now faces mounting negligence accusations from Xarelto patients across the U.S. And that’s in addition to wrongful death cases filed by victims’ surviving family members. The manufacturer allegedly failed to warn consumers about all potential side effect risks, echoing the FDA’s previous concerns. Reviewing Xarelto lawsuit information shows many plaintiffs say their doctors weren’t properly informed about not having an antidote to reverse uncontrolled bleeding. Allegations, plaintiffs’ names as well as other relevant Xarelto lawsuit information, is centralized under a multi-district litigation set for trial in February 2017.
Notably, this isn’t the first time a new wave blood thinner medication fell under public scrutiny. Another anticoagulant called Pradaxa (dabigatran) faces failure to warn lawsuits from injured consumers. Pradaxa as well as Xarelto share many side effects with blood thinner medication Eliquis, also now facing product liability lawsuits. Plaintiffs researching Eliquis, Pradaxa or Xarelto lawsuit information are likely to see the same allegations cited across different drug injury cases, since they’re all newer anticoagulants.
Check eligibility for compensation.
If you or a loved one experienced blood clots, uncontrolled bleeding or death while taking Xarelto, you may qualify for financial compensation from the manufacturer. Request your free case evaluation now to see if you may qualify.